Table 1: Clinical electrophysiological and laboratory findings of patients.
Age/sex |
Days between COVID-19 symptoms and GBS onset |
Neurological examaination |
Chest radiographic features
|
GBS symptoms (GBS/Clinical) |
GBS elec- trophysiologic subtype |
CSF findings |
Previous comorbidities |
Blood fndings |
|
1.75/M |
15 days after |
Proximal and distal lower limb weakness, hypoactive deep tendon refexes in upperlimb and absent in lowerlimb |
Yes |
Progression of limb weakness and inability o walk Loss of ambulation, AMAN |
MAN |
Increased total protein (56.61 mg/dl). |
HT |
Ferritin 1079 ng/ml Lymphopenia 0.6 × 9 × 109/L Thrombocytopenia (140 × 109/L, |
|
2.74/FM |
17 days after |
Hypoaesthesia, paraparesis paraesthesia in the lowerlimb |
Yes |
Hypoaesthesia, weakness paraesthesia in the lowerlimb AMSAN |
MSAN |
Increased total protein (78.39 mg/dl). |
HT |
Ferritin 247 ng/ml Lymphopenia 0.22 × 9 × 109/L Thrombocytopenia (102 × 109/L, |
|
3.80/FM |
19 days after |
Paraparesis, pain in the lowerlimband hyporeflexia at the lowerlimb |
No |
Lowerlimb weakness, and difficulty walkingAMAN
|
MAN |
|
HT |
Ferritin 466 ng/ml Lymphopenia 0.77 × 9 × 109/L |
|
4.80/FM |
12 days after |
Paraparesis, paresthesia pain and arerefexia at the lowerlimb/hyporeflexia in the upperlimb |
Yes |
Progressive ascending paraesthesia of distal lowerlimb, loss of ambulation AMSAN |
MSAN |
|
HT |
Ferritin 597 ng/ml Lymphopenia 0.44 × 9 × 109/L Thrombocytopenia (143 × 109/L, |
|
5.70/FM |
16 days after |
Paraparesis, and arereflexia at the lowerlimb |
Yes |
Flaccidparaparesis, arefexia at lowerlimb and loss of ambulation AMAN |
MAN |
|
HT |
Ferritin 487.2 ng/ml
|
|
6.83/FM |
16 days after |
Lower limb weakness, hypoactive deeptendon reflexes in Uupperlimb and absent in lowerlimb |
Yes |
lowerlimb paraesthesia and paraparesis, difficulty walking AMSAN |
MSAN |
|
HT |
Ferritin 910 ng/ml Lymphopenia 0.56 × 9 × 109/L Thrombocytopenia (124 × 109/L |
|
7.82/FM |
12 days after |
Lowerlimb weakness, hypoactive and absent in lowerlimb |
Yes |
lowerlimb paraparesis difficulty walking AMAN |
MAN |
Increased total protein (91.05 mg/dl). |
HT |
Ferritin 986 ng/ml |
|
8.57/FM |
18 days after |
Tetraparesis, generalized areflexia, hypoesthesia in the 4 limbs |
No |
Ascendant weakness Tetraparesis, generalized, sensoryloss. weakness in four limbs AMSAN
|
MSAN |
normal total protein (47.12 mg/dl). |
No comorbid diseases |
Ferritin 906.2 ng/ml
|
|
9.75/FM |
11 days after |
Flaccid paraparesis, paresthesia generalized arefexia |
Yes |
paraparesis, generalized, sensoryloss AMSAN |
MSAN |
|
HT |
Ferritin 1015 ng/ml Lymphopenia 0.96 × 9 × 109/L Thrombocytopenia (117 × 109/L, |
|
10.72/FM |
17 days after |
Ascending weakness, paraparesis and paresthesia hypoactive deep tendonreflexes in upperlimb and absent in lowerlimb |
Yes |
Lowerlimb paraesthesia and weakness AMSAN |
MSAN |
|
No comorbid diseases |
Ferritin 1402 ng/ml Lymphopenia 1.02 × 9 × 109/L |
|
11. 67/M |
63 day |
Ascending weakness, paraparesis hypoactive deeptendon refexes in lowerlimb |
Yes |
Lowerlimb weakness, and difficulty walking AMAN
|
MAN |
|
No comorbid diseases |
Lymphopenia 0.29 × 9 × 109/L Thrombocytopenia (248 × 109/L |
|
12. 68/M |
30 |
Tetraparesis, generalized hypoactive deeptendon reflexes, hypoesthesia in the 4 limbs |
Yes |
Ascendant weakness Tetraparesis, generalized, sensoryloss. weakness in four limbs AIDP |
Sensoriel predominant IDP |
|
No comorbid disease |
Ferritin 1219 ng/ml Lymphopenia 0.94 × 9 × 109/L Thrombocytopenia (141 × 109/L |
|
13. 49/FM |
35 |
Tetraparesis, generalized areflexia, hypoesthesia in the 4 limbs |
No |
Ascendant weakness Tetraparesis, generalized, sensory loss. weakness in four limbs AMAN
|
MAN |
Increased total protein (82.08 mg/dl). |
No comorbid disease |
Lymphopenia 1 × 9 × 109/L |
|
14. 33/FM |
15 |
Lowerlimb weakness, hypoactive reflexes in lowerlimbs |
No |
paraparesis, generalized, sensoryloss AMSAN |
MSAN |
|
No comorbid disease |
N |
|
15. 36/FM |
18 |
Generalized hyporeflexia, hypoesthesia in the 4 limbs |
No |
sensoryloss. in four limbs AMAN
|
MAN |
|
No comorbid disease |
Ferritin 2491 ng/ml Lymphopenia 0.94 × 9 × 109/L |
|
16. 29/FM |
60 |
Generalized areflexia, hypoesthesia in the 4 limbs |
No |
sensoryloss. in four limbs AIDP
|
Sensoriel predominant IDP |
|
No comorbid disease |
N |
HT: Hypertension; Ferritin: 13-150 ng/ml; Platelet: 150-450 × 109/L; Lenfosit: 1.26-3.35 9 × 109/L AMAN: Acute Motor Axonal Neuropathy; AMSAN: Acute Motor Sensory Axonal Neuropathy; AIDP: Acute Inflamatory demiyelinating polyneuropathy; MAN: Motor Axonal Neuropathy; MSAN: Motor Sensory Axonal Neuropathy; IDP: Inflamatory demiyelinating polyneuropathy